Skip to content
10-Q

Quarterly Report

JRSIS HEALTH CARE CORPORATION JRSS

0001213900-23-087269

← back to feed
Filed
Nov 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 13, 2023 5.84M sh
Cash And Equivalents Q3 2023 · Sep 30, 2023 $33.39K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $58.62K
Stockholders Equity Q3 2023 · Sep 30, 2023 $473.73K
Stockholders Equity Q3 2023 · Jun 30, 2023 $591.99K
Stockholders Equity Q3 2023 · Mar 31, 2023 $691.9K
Stockholders Equity Q3 2023 · Dec 31, 2022 $811.32K
Stockholders Equity Q3 2023 · Sep 30, 2022 $860.78K
Stockholders Equity Q3 2023 · Jun 30, 2022 $989.5K
Stockholders Equity Q3 2023 · Mar 31, 2022 $35.95M
Stockholders Equity restated Q3 2023 · Dec 31, 2021 $33.1M
Current Liabilities Q3 2023 · Sep 30, 2023 $90.97K
Current Liabilities Q3 2023 · Dec 31, 2022 $43.23K
Total Liabilities Q3 2023 · Sep 30, 2023 $90.97K
Total Liabilities Q3 2023 · Dec 31, 2022 $44.66K
Current Assets Q3 2023 · Sep 30, 2023 $527.15K
Current Assets Q3 2023 · Dec 31, 2022 $798.85K
Total Assets Q3 2023 · Sep 30, 2023 $564.7K
Total Assets Q3 2023 · Dec 31, 2022 $855.98K
Shares Diluted restated Q3 2023 · Sep 30, 2022 5.84M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 4.06M sh
Capex Q3 2023 · Sep 30, 2022 $46.37K
Operating Cash Flow Q3 2023 · Sep 30, 2022 $3M
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$0.02
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$8.30
Eps Basic restated Q3 2023 · Sep 30, 2022 −$0.02
Eps Basic restated Q3 2023 · Sep 30, 2022 −$8.30
Net Income Q3 2023 · Sep 30, 2022 −$132.46K
Net Income Q3 2023 · Sep 30, 2022 −$33.68M
Operating Income Q3 2023 · Sep 30, 2022 −$132.46K
Operating Income Q3 2023 · Sep 30, 2022 −$282.07K